Delivery Order SPE2DE24D0013-SPE2D626F11MP

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,200 to Cepheid Inc. on January 15, 2026, for diagnostic reagents and test kits under an existing Indefinite Delivery Contract framework. This firm fixed-price delivery order, designated XPRS4PLEX-10, is scheduled for completion by January 23, 2026, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of molecular diagnostic solutions. This delivery order represents ongoing procurement through DLA Medical Supply Chain's established contracting vehicle for essential diagnostic supplies supporting federal healthcare operations.

Cepheid, a leading manufacturer of advanced molecular diagnostic systems, has established itself as a critical supplier across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company specializes in rapid molecular diagnostic testing platforms, most notably the GeneXpert diagnostic system and associated reagents for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus, tuberculosis, and other pathogens. Cepheid holds substantial framework contracts with the VA, including a $32.8 million Indefinite Delivery Contract with VISN 6 extending through September 2030, which has generated numerous delivery orders supporting clinical laboratory operations across the VA's distributed network of medical centers.